- 【Updated on May 12, 2025】 Integration of CiNii Dissertations and CiNii Books into CiNii Research
- Trial version of CiNii Research Knowledge Graph Search feature is available on CiNii Labs
- Suspension and deletion of data provided by Nikkei BP
- Regarding the recording of “Research Data” and “Evidence Data”
TWO CASES OF CEREBRAL VESSEL DISEASE FOLLOWING HIGH DOSE INTRAVASCULAR IMMUNOGLOBULIN THERAPY
-
- Sugimoto Takeshi
- Division of Transfusion Medicine, Kobe University Hospital Clinical Immunology, Kobe University Hospital
-
- Saigo Katsuyasu
- Faculty of Pharmaceutical Sciences, Himeji Dokkyo University
-
- Nakazawa Takashi
- Department of Rheumatology, Kurashiki Central Hospital
-
- Tsuji Gou
- Clinical Immunology, Kobe University Hospital
-
- Mamehara Akira
- Clinical Immunology, Kobe University Hospital
-
- Misaki Kenta
- Clinical Immunology, Kobe University Hospital
-
- Namiki Mitsuo
- Internal Medicine, Kobe Century Memorial Hospital
-
- Hayashi Hiroki
- Clinical Immunology, Kobe University Hospital
-
- Hashimoto Makoto
- Division of Transfusion Medicine, Kobe University Hospital
-
- Sakurai Kousuke
- Division of Transfusion Medicine, Kobe University Hospital
-
- Kumagai Syunichi
- Division of Transfusion Medicine, Kobe University Hospital Clinical Immunology, Kobe University Hospital
Bibliographic Information
- Other Title
-
- 免疫グロブリン大量点滴静注療法(IVIG)の関与が考えられる脳血管障害例
Search this article
Description
Background: Vascular injury, such as thrombotic complications, is known to occur as a side effect of high dose intravascular immunoglobulin therapy (IVIG therapy). Here, we report two cases of cerebral vessel disease.<br> Case 1: In September 2006, a 67-year old man, complicating of muscle insufficiency in the lower extremities, was diagnosed with sigmoid cancer and polymyositis with complicated aspiration pneumonia. Although antibiotic therapy for pneumonia, IVIG therapy for polymyositis, and surgical operative therapy for sigmoid cancer were performed, the patient died due to hemorrhage of the bilateral thalamus. <br> Case 2: In May 2006, a 62-year old man, who had previous history of pyoderma gangrenosum and myelodysplastic syndrome, suffered from fever and red blisters in the palm of his right hand. He was diagnosed with the recurrent pyoderma gangrenosum and necrotizing fasciitis. Although intensive therapy was performed using IVIG, antibiotics, mPSL pulse, and cyclosporine A, the patient died due to multiple cerebral infarction (right middle artery area, right posterior artery area, and cerebella area).<br> Discussion: Both cases show the possible difficulties of cerebral vessel complication in IVIG therapy. These observations suggest that further risk-value analysis is required to better assess cerebral vessel complications in IVIG therapy.<br>
Journal
-
- Japanese Journal of Transfusion and Cell Therapy
-
Japanese Journal of Transfusion and Cell Therapy 55 (5), 617-623, 2009
The Japan Society of Transfusion Medicine and Cell Therapy
- Tweet
Details 詳細情報について
-
- CRID
- 1390282680248026112
-
- NII Article ID
- 10026334226
-
- NII Book ID
- AA12159645
-
- ISSN
- 18830625
- 18813011
-
- Text Lang
- ja
-
- Data Source
-
- JaLC
- Crossref
- CiNii Articles
-
- Abstract License Flag
- Disallowed